Evoke Pharma (EVOK) SEC Filings & 10K Form → A new way to collect income from stocks (From DTI) (Ad) Free EVOK Stock Alerts $0.46 +0.02 (+4.57%) (As of 04/26/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Recent Evoke Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/10/20242:34 PMEvoke Pharma (Filer)Form DEF 14A04/10/20242:35 PMEvoke Pharma (Filer)Form DEFA14A04/10/20242:36 PMEvoke Pharma (Filer)Form ARS03/25/20243:55 PMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/25/20243:56 PMEvoke Pharma (Filer)Form 424B303/21/20243:15 PMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/13/202412:32 PMEvoke Pharma (Subject)LYTTON LAURENCE W (Filed by)Form SC 13G Get the Latest News and Ratings for EVOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter. 03/11/20245:39 PMBleichroeder LP (Filed by)Evoke Pharma (Subject)Form SC 13G02/23/20243:15 PMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/20/20243:38 PMAltium Capital Management LP (Filed by)Evoke Pharma (Subject)Form SC 13G02/13/20245:34 AMEvoke Pharma (Subject)HIRSCHMAN ORIN (Filed by)Form SC 13G02/09/20244:15 PMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/08/202411:15 PMEvoke Pharma (Filer)Form EFFECT02/08/20245:50 AMEvoke Pharma (Filer)Form S-1/A01/10/20248:38 PMEvoke Pharma (Filer)Form S-1/A12/19/20237:30 AMEvoke Pharma (Filer)Form S-1/A12/15/20233:30 PMEvoke Pharma (Filer)Form S-1/A11/29/20238:00 AMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/27/20233:30 PMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/22/20233:15 PMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/09/20238:00 AMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/09/20238:00 AMEvoke Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/01/20237:30 AMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/12/20233:30 PMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/11/20238:01 AMEvoke Pharma (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 08/10/20238:00 AMEvoke Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/10/20238:03 AMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/21/20238:00 AMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/20233:02 PMEvoke Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/09/20239:00 AMEvoke Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: CING 10K Form VRPX 10K Form BPTS 10K Form MBIO 10K Form KTRA 10K Form NEXI 10K Form THAR 10K Form ZVSA 10K Form PCSA 10K Form GNPX 10K Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:EVOK) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
